Kiora Pharmaceuticals’ (KPRX) “Buy” Rating Reaffirmed at HC Wainwright
HC Wainwright reissued their buy rating on shares of Kiora Pharmaceuticals (NASDAQ:KPRX – Free Report) in a research report report published on Friday,Benzinga reports. The firm currently has a $10.00 price target on the stock. Kiora Pharmaceuticals Stock Performance Shares of KPRX stock opened at $3.08 on Friday. The company has a market capitalization of […]
